ORCL vs ZVRA · P/E 31, rev $67.36B vs P/E 6.3, rev $75.9M
Oracle Corporation (ORCL) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the ORCL and ZVRA stock pages for the full models.
Not investment advice.